BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16418399)

  • 1. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity.
    Woelbing F; Kostka SL; Moelle K; Belkaid Y; Sunderkoetter C; Verbeek S; Waisman A; Nigg AP; Knop J; Udey MC; von Stebut E
    J Exp Med; 2006 Jan; 203(1):177-88. PubMed ID: 16418399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells in Leishmania major infections: mechanisms of parasite uptake, cell activation and evidence for physiological relevance.
    Kautz-Neu K; Schwonberg K; Fischer MR; Schermann AI; von Stebut E
    Med Microbiol Immunol; 2012 Nov; 201(4):581-92. PubMed ID: 22983754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against
    Osero BO; Cele Z; Aruleba RT; Maine RA; Ozturk M; Lutz MB; Brombacher F; Hurdayal R
    Front Immunol; 2021; 12():759021. PubMed ID: 35154068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive, natural IgG recognizing L. major promote parasite internalization by dendritic cells and promote protective immunity.
    Dermicik F; Lopez Kostka S; Tenzer S; Waisman A; Von Stebut E
    J Mol Med (Berl); 2022 Mar; 100(3):451-460. PubMed ID: 34604942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
    von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
    Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice.
    Martínez-López M; Iborra S; Conde-Garrosa R; Sancho D
    Eur J Immunol; 2015 Jan; 45(1):119-29. PubMed ID: 25312824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dectin-1 Positive Dendritic Cells Expand after Infection with
    Zimara N; Chanyalew M; Aseffa A; van Zandbergen G; Lepenies B; Schmid M; Weiss R; Rascle A; Wege AK; Jantsch J; Schatz V; Brown GD; Ritter U
    Front Immunol; 2018; 9():263. PubMed ID: 29535708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.
    Thomas BN; Buxbaum LU
    Infect Immun; 2008 Feb; 76(2):623-31. PubMed ID: 18070890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major.
    Lemos MP; Esquivel F; Scott P; Laufer TM
    J Exp Med; 2004 Mar; 199(5):725-30. PubMed ID: 14993255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity.
    Matos I; Mizenina O; Lubkin A; Steinman RM; Idoyaga J
    PLoS One; 2013; 8(6):e67453. PubMed ID: 23840706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous leishmaniasis: Distinct functions of dendritic cells and macrophages in the interaction of the host immune system with Leishmania major.
    von Stebut E; Tenzer S
    Int J Med Microbiol; 2018 Jan; 308(1):206-214. PubMed ID: 29129568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection.
    Hurdayal R; Nieuwenhuizen NE; Revaz-Breton M; Smith L; Hoving JC; Parihar SP; Reizis B; Brombacher F
    PLoS Pathog; 2013 Oct; 9(10):e1003699. PubMed ID: 24204259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H; Flohé S; Röllinghoff M
    Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity.
    von Stebut E; Belkaid Y; Jakob T; Sacks DL; Udey MC
    J Exp Med; 1998 Oct; 188(8):1547-52. PubMed ID: 9782133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response.
    Erb K; Blank C; Ritter U; Bluethmann H; Moll H
    Immunobiology; 1996 Jul; 195(2):243-60. PubMed ID: 8877400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
    Okwor I; Jia P; Uzonna JE
    J Immunol; 2015 Oct; 195(7):3218-26. PubMed ID: 26304989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with TAT-antigen fusion protein induces protective, CD8(+) T cell-mediated immunity against Leishmania major.
    Kronenberg K; Brosch S; Butsch F; Tada Y; Shibagaki N; Udey MC; von Stebut E
    J Invest Dermatol; 2010 Nov; 130(11):2602-10. PubMed ID: 20574442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for leukocyte-derived IL-1RA in DC homeostasis revealed by increased susceptibility of IL-1RA-deficient mice to cutaneous leishmaniasis.
    Kautz-Neu K; Kostka SL; Dinges S; Iwakura Y; Udey MC; von Stebut E
    J Invest Dermatol; 2011 Aug; 131(8):1650-9. PubMed ID: 21525884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-presenting dendritic cells are required for control of Leishmania major infection.
    Ashok D; Schuster S; Ronet C; Rosa M; Mack V; Lavanchy C; Marraco SF; Fasel N; Murphy KM; Tacchini-Cottier F; Acha-Orbea H
    Eur J Immunol; 2014 May; 44(5):1422-32. PubMed ID: 24643576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 signalling is dispensable for protective immunity in Leishmania-resistant mice.
    Kautz-Neu K; Kostka SL; Dinges S; Iwakura Y; Udey MC; von Stebut E
    Exp Dermatol; 2011 Jan; 20(1):76-8. PubMed ID: 20955202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.